IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
UP-0080790
(2005-03-15)
|
등록번호 |
US-7785619
(2010-09-20)
|
발명자
/ 주소 |
- Moneymaker, Ricky Dean
- Klesman, Larry Scott
- Theus, Jon Scott
|
출원인 / 주소 |
|
대리인 / 주소 |
McAndrews Held & Malloy, Ltd.
|
인용정보 |
피인용 횟수 :
0 인용 특허 :
31 |
초록
▼
Individualized responsive dosing pharmanutrient systems, compositions, methods of dosing, and processes of producing the same, which allow a consumer to generate individualistic biological responses/effects. More specifically, a pharmanutrient system for generating individualized biological conditio
Individualized responsive dosing pharmanutrient systems, compositions, methods of dosing, and processes of producing the same, which allow a consumer to generate individualistic biological responses/effects. More specifically, a pharmanutrient system for generating individualized biological conditions/responses which utilizes ultra-low dosage amounts of vitamins, minerals, amino acids, co-enzymes, organics substrates, inorganic or synthetic substrates, biological components, and/or other nutrients incorporated or provided with a pharmacologically active ingredient in a bio-active delivery system which preferably avoids first pass metabolism, such that an individual may take multiple doses of the same or different pharmanutrient based on varying desired biological response within each dosing period.
대표청구항
▼
What is claimed: 1. A pharmanutrient dosing method comprising selecting from two or more different formulations provided as oral strips, sublingual liquids or sprays which substantially avoid first pass metabolism, wherein each pharmanutrient formulation comprises five or more of the following in a
What is claimed: 1. A pharmanutrient dosing method comprising selecting from two or more different formulations provided as oral strips, sublingual liquids or sprays which substantially avoid first pass metabolism, wherein each pharmanutrient formulation comprises five or more of the following in an amount equal to about 5 drops in a liquid: about 2.77×10−7 g magnesium; about 4.16×10−7 g sodium; about 1.09×10−6 g potassium; about 2.93×10−7 g calcium; about 2.31×10−6 g ascorbic acid; about 2.19×10−7 g caffeine; about 4.62×10−8 g niacin; about 1.73×10−9 g chromium; about 1.44×10−7 g coenzyme Q-10; about 1.16×10−6 g L-glutamine about 4.76×10−8 g vitamin A; about 8.33×10−10 g vitamin B1; about 6.29×10−1° q vitamin B2; about 8.02×10−9 g vitamin B3; about 8.02×10−9 g vitamin B6; about 2.41×10−12 g vitamin B12; about 2.41×10−8 g vitamin C; about 3.81×10−9 g vitamin D3; about 2.78×10−10 g vitamin E; about 7.22×10−11 g vitamin H; about 7.7×10−11 g folic acid; about 3.53×10−10 g copper; about 3.06×10−9 g iron; or about 2.58×10−9 g zinc, and further wherein at least one of the two or more different formulations comprises: at least one other pharmacologically active ingredient selected from the group consisting of analgesic agents, antihistamines, antacids, antiflatulants, laxatives, antidiarrheals, and stimulants; and administering the selected formulation to a recipient which substantially avoids first pass metabolism. 2. The method of claim 1, wherein the vitamins, minerals, amino acids, or co-enzyme Q-10 include at least five or more of the members of the group consisting of: vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B12, vitamin C, vitamin D3, vitamin E, vitamin H, folic acid, copper, iron, potassium iodide, calcium carbonate, and zinc.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.